株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

薬物依存症:世界の治験レビュー

Drug Addiction Global Clinical Trials Review, H2, 2017

発行 GlobalData 商品コード 306662
出版日 ページ情報 英文 606 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.19円で換算しております。
Back to Top
薬物依存症:世界の治験レビュー Drug Addiction Global Clinical Trials Review, H2, 2017
出版日: 2017年07月26日 ページ情報: 英文 606 Pages
概要

当レポートでは、薬物依存症に関する臨床研究の最新動向について分析し、疾患治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、地域フェーズ(相)段階別の進行状況、有望なスポンサー、各企業研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

目次

イントロダクション

  • 薬物依存症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋の主要国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東およびアフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:中枢神経系疾患の治験件数に対する薬物依存症の治験件数比率

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7(新興7ヶ国)諸国での治験件数:中枢神経系疾患の治験件数に対する薬物依存症の治験件数比率

E7(新興7ヶ国)諸国での治験件数:フェーズ(相)別

E7(新興7ヶ国)諸国での治験件数:進捗状況別

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ別

進捗状況別の治験件数

エンドポイント達成状況別の治験件数

未達成の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

有望な薬剤

薬物依存症における最新の治験情報

治験のプロファイル

  • 代表的企業の治験の概要
    • RTI International
    • Johnson & Johnson
    • Alkermes Inc. (Inactive)
    • SK Holdings Co., Ltd.
    • Reckitt Benckiser Group Plc
    • GlaxoSmithKline plc
    • Embera NeuroTherapeutics, Inc.
    • Catalyst Pharmaceutical Partners, Inc.
    • Gilead Sciences, Inc.
    • D&A Pharma SAS
  • 代表的な研究機関・病院の治験の概要
    • National Institute on Drug Abuse
    • Yale University
    • University of Pennsylvania
    • New York State Psychiatric Institute
    • University of California, Los Angeles
    • Johns Hopkins University
    • Medical University of South Carolina
    • Baylor College of Medicine
    • University of Arkansas
    • University of Kentucky

5つの代表的な治験のプロファイル

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC4399CTIDB

GlobalData's clinical trial report, "Drug Addiction Global Clinical Trials Review, H2, 2017" provides an overview of Drug Addiction clinical trials scenario. This report provides top line data relating to the clinical trials on Drug Addiction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by G7 Countries: Proportion of Drug Addiction to Central Nervous System Clinical Trials 16
  • Clinical Trials by Phase in G7 Countries 18
  • Clinical Trials in G7 Countries by Trial Status 19
  • Clinical Trials by E7 Countries: Proportion of Drug Addiction to Central Nervous System Clinical Trials 21
  • Clinical Trials by Phase in E7 Countries 23
  • Clinical Trials in E7 Countries by Trial Status 24
  • Clinical Trials by Phase 26
  • In Progress Trials by Phase 27
  • Clinical Trials by Trial Status 28
  • Clinical Trials by End Point Status 30
  • Subjects Recruited Over a Period of Time 31
  • Clinical Trials by Sponsor Type 32
  • Prominent Sponsors 33
  • Top Companies Participating in Drug Addiction Therapeutics Clinical Trials 35
  • Prominent Drugs 37
  • Clinical Trial Profile Snapshots 38

Appendix 604

  • Abbreviations 604
  • Definitions 604
  • Research Methodology 605
  • Secondary Research 605
  • About GlobalData 606
  • Contact Us 606
  • Source 606

List of Tables

List of Tables

  • Drug Addiction Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Drug Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Drug Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Drug Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
  • Drug Addiction Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
  • Drug Addiction Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
  • Drug Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14
  • Drug Addiction Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 15
  • Proportion of Drug Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 17
  • Drug Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
  • Drug Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Proportion of Drug Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 22
  • Drug Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23
  • Drug Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 25
  • Drug Addiction Therapeutics, Global, Clinical Trials by Phase, 2017* 26
  • Drug Addiction Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 27
  • Drug Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2017* 29
  • Drug Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30
  • Drug Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31
  • Drug Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 32
  • Drug Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 34
  • Drug Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 36
  • Drug Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 37

List of Figures

List of Figures

  • Drug Addiction Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Drug Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Drug Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Drug Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
  • Drug Addiction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
  • Drug Addiction Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
  • Drug Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 14
  • Drug Addiction Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 15
  • Proportion of Drug Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 16
  • Drug Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
  • Drug Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Proportion of Drug Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 21
  • Drug Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23
  • Drug Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 24
  • Drug Addiction Therapeutics, Global, Clinical Trials by Phase (%), 2017* 26
  • Drug Addiction Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 27
  • Drug Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2017* 28
  • Drug Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30
  • Drug Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31
  • Drug Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 32
  • Drug Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 33
  • Drug Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 35
  • Drug Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 37
  • GlobalData Methodology 605
Back to Top